Associate Scientist/Scientist preclinical pipeline development, One-year temporary position
Zelluna Immunotherapy As
Frist 14\.6\.2026
Ansettelsesform Engasjement
Join Zelluna Immunotherapy as Associate Scientist/Scientist
Zelluna Immunotherapy is an exciting and dynamic start\-up based in Oslo specializing in T cell receptor (TCR) cell therapies, built around a distinctive scientific approach. The company is developing TCR\-guided natural killer (TCR\-NK) cells as an allogeneic, off\-the\-shelf cellular therapy for patients with solid tumors.
The first clinical trial, ZIMA\-101, evaluating our TCR\-NK product in ovarian cancer, squamous non\-small cell lung cancer, synovial sarcoma, and head and neck cancer, was initiated in the second quarter of 2026\.
We are now seeking an experienced cellular biologist or immunologist for a one\-year temporary position to support the continued development and expansion of our TCR\-NK pipeline. The ideal candidate is passionate about our approach, thrives in a fast\-paced, continuously learning start\-up environment, and is motivated to collaborate closely with a team dedicated to delivering on our shared mission.
Key Responsibilities
Under senior supervision, plan, initiate, and execute laboratory work to advance company objectives, meeting agreed timelines and milestones
Isolate and culture human immune cells and perform functional T and NK cell assays
Screen TCR candidates using in vitro assays to select the most specific and potent candidates for further in\-depth analysis including flow cytometry and imaging based functional analysis
Ensure accurate, timely, and high\-quality recording of all data and experimental information
Adhere to established laboratory procedures and effectively utilize Zelluna’s internal quality system
Contribute to a collaborative team culture characterized by engagement, enthusiasm, scientific rigor, and continuous improvement
Basic requirements
MSc with minimum 3 years of relevant experience or PhD in Cellular Biology, Molecular Biology, Immunology or a related discipline
Hands\-on experience in the following areas within the last three years:
Isolation and expansion of primary T and/or NK cells, as well as primary cell and cell line culture
Expertise in T and/or NK cell\-based assays (e.g., ELISA, ELISpot, large panel flow cytometry, advanced cytotoxicity assays)
Competency in molecular biology
Experience with engineered cell systems preferred; industry experience is an advantage
Demonstrated ability to integrate and interpret data from multiple sources to drive scientific progress
Strong attention to detail and commitment to high\-quality documentation standards
Motivation to work in a start\-up environment with a proactive, hands\-on (“roll up your sleeves”) mindset
Strong teamwork skills with a flexible and solution\-oriented attitude
Fluency in English, with excellent written and verbal communication skills
We offer a one\-year temporary contract, based at our headquarters in Oslo, Norway.
We are on an exciting journey \- join us, so together we can build the science, shape the culture and make a difference to the lives of cancer patients.
Ferdigheter
Celle\- og molekylærbiologi
Cellekultivering
Flowcytometri
Immunologi
Molekylærbiologi
Om arbeidsgiveren
Zelluna Immunotherapy is an exciting and dynamic start\-up based in Oslo specializing in T cell receptor (TCR) cell therapies, built around a distinctive scientific approach.
The company is developing TCR\-guided natural killer (TCR\-NK) cells as an allogeneic, off\-the\-shelf cellular therapy for patients with solid tumors.
Sektor: Privat
Sted: Ullernchausseen 64, 0379 Oslo
Hjemmekontor: På kontoret
Bransje: Farmasi og legemiddel, Forskning, utdanning og vitenskap
Stillingsfunksjon: Forskning/Stipendiat/Postdoktor
Arbeidsspråk: Engelsk
Nøkkelord
cellebiologi, immunologi, t\-celler, bioteknologi, celleterapi
Spørsmål om stillingen
--------------------------
- Kontaktperson: Sylvie Pollmann
- Stillingstittel: Sr. Group Leader Preclinical Research
This listing is from indeed. View original listing ↗